ORFLO Announces Collaboration with Penn Medicine

ORFLO Announces Collaboration with Penn Medicine to Benchmark Moxi Go II for Simultaneous Cell Count, Cell Volume, Cell Viability Assessment Against Current Standards, Critical in the Manufacturing Process of CART Cells Used for Immunotherapies. Click here for more details.